C-reactive protein-mediated vascular injury requires complement

Academic Article

Abstract

  • Background: We previously demonstrated that vascular injury-induced neointima formation is exaggerated in human C-reactive protein (CRP) transgenic (CRPtg) compared to nontransgenic (NTG) mice. We now test the hypothesis that complement is required for this effect. Methods and results: CRPtg and NTG with a normal complement system versus their counterparts lacking expression of complement component 3 (C3) protein (CRPtg/C3 and NTG/C3 ) underwent carotid artery ligation. Twenty-eight days later, the injured vessels in CRPtg had thicker neointimas and more immunoreactive C3 in the surrounding adventitia compared with NTG. In CRPtg/C3 , there was no increase in neointimal thickness compared with NTG or NTG/C3 . Decreasing human CRP blood levels through administration of a selective antisense oligonucleotide eliminated the depletion of serum C3 associated with vascular injury and reduced immunoreactive C3 in the resultant lesions. In injured vessels, C3 colocalized with F4/80 (macrophage marker), and in vitro, human CRP elicited increased expression of C3 by bone marrow-derived macrophages. Conclusion: Human CRP exaggeration of neointima formation in injured mouse carotid arteries associates with decreased circulating C3 and increased tissue-localized C3. C3 elimination or pharmacological reduction of human CRP prevents CRP-driven exacerbation of the injury response. In the CRPtg model system, mouse C3 is essential for the effect of human CRP. © 2010 American Heart Association, Inc. -/- -/- -/- -/-
  • Digital Object Identifier (doi)

    Author List

  • Hage FG; Oparil S; Xing D; Chen YF; McCrory MA; Szalai AJ
  • Start Page

  • 1189
  • End Page

  • 1195
  • Volume

  • 30
  • Issue

  • 6